Valeant agrees to buy Medicis for $2.6B
Valeant Pharmaceuticals International Inc. has agreed to buy Scottsdale-based dermatology products maker Medicis Pharmaceutical Corp. for about $2.6 billion in cash in a deal to strengthen its position in skin…
